Itonis, Inc. (ITNS) Stock
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Itonis, Inc.
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Itonis, Inc. (ITNS) stock trades at $0.00 with a market capitalization of $609364. The stock is valued at a price-to-earnings (P/E) ratio of -53.86, price-to-book of -0.53, price-to-sales of 8200.30. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Itonis, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of 0.99%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.itonisholdings.com